NBIXNeurocrine Biosciences, Inc.
NBIX
Neurocrine Biosciences, Inc.3,246
Mkt Cap
$13.21BVolume
706,967.0052W High
$160.1852W Low
$84.23PE Ratio
28.19NBIX Fundamentals
Price
$131.60Prev Close
$132.56Open
$130.8150D MA
$131.92Beta
0.75Avg. Volume
994,323.26EPS (Annual)
$4.67P/B
4.05Rev/Employee
$1.43M$13,528.48
8,437 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Nilsine Partners LLC
Nilsine Partners LLC purchased a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 11.2% during the 4th quarter, according to its most recent filing with...
MarketBeat·2d ago
Wealth Enhancement Advisory Services LLC Boosts Stake in Neurocrine Biosciences, Inc. $NBIX
Wealth Enhancement Advisory Services LLC grew its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure...
MarketBeat·6d ago
SG Americas Securities LLC Buys 119,339 Shares of Neurocrine Biosciences, Inc. $NBIX
SG Americas Securities LLC increased its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 785.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 134,530 shares of the compan...
MarketBeat·7d ago
Nordea Investment Management AB Increases Stake in Neurocrine Biosciences, Inc. $NBIX
Nordea Investment Management AB boosted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 81.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 27,202 shares of the company's stock after acquiring an additional 12,195 shares...
MarketBeat·7d ago
Assenagon Asset Management S.A. Has $11.35 Million Stock Position in Neurocrine Biosciences, Inc. $NBIX
Assenagon Asset Management S.A. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 70.4% in the fourth quarter, according to the company in its most recent...
MarketBeat·7d ago
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings Neurocrine Biosciences Presents First Expert Consensus Recommendations for...
PR Newswire·9d ago
CIBC Private Wealth Group LLC Grows Stock Position in Neurocrine Biosciences, Inc. $NBIX
CIBC Private Wealth Group LLC boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 17,250.0% during the third quarter, according to the company in its most recent...
MarketBeat·12d ago
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Hudson Bay Capital Management LP
Hudson Bay Capital Management LP decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 47.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,510 shares of the company's st...
MarketBeat·14d ago
Neurocrine Biosciences Maps 2026 Execution, Data-Rich 2027; Ingrezza Guides $2.7B $2.8B
Neurocrine Biosciences (NASDAQ:NBIX) executives used a conference discussion to frame 2026 as a year of execution ahead of what they described as a data-rich 2027 across multiple mid- and late-stage...
MarketBeat·14d ago
<
1
2
...
>